About the Authors
- Ken Matsui
-
Affiliation Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
- Joseph W. Adelsberger
-
Affiliation AIDS Monitoring Laboratory, Clinical Service Program, Applied and Developmental Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
- Troy J. Kemp
-
Affiliation Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
- Michael W. Baseler
-
Affiliation AIDS Monitoring Laboratory, Clinical Service Program, Applied and Developmental Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
- Julie E. Ledgerwood
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Ligia A. Pinto
-
* E-mail: pintol@mail.nih.gov
Affiliation Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: KM TJK LAP. Performed the experiments: KM JWA. Analyzed the data: KM JWA TJK LAP. Contributed reagents/materials/analysis tools: JWA MWB JEL. Wrote the paper: KM TJK LAP. Conducted the VRC 902 Study: JEL. Reviewed the data and read the manuscript: KM JWA TJK MWB JEL LAP. Oversight of the study: LAP.